Skip to content

Interventional study for the assessment of medication adherence in adult hypertensive out-patients in a tertiary care hospital in rural haryana

Interventional study for the assessment of medication adherence in adult hypertensive out-patients in a tertiary care hospital in rural haryana - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072120
Enrollment
106
Registered
2024-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Educational Intervention: Non-adherent patients will be randomly divided into two study groups i.e., Group A and Group B. Each study group will receive the following-. Group A – intera

Sponsors

SHKM GMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Essential Hypertension on oral anti-hypertensive drugs for at least 1 month visiting the medicine OPD of SHKM GMC. Hypertensive patients on oral anti-hypertensive therapy. Patients who are willing to give written informed consent.

Exclusion criteria

Exclusion criteria: Patients of secondary hypertension Patients with severe comorbidities or cognitive impairments that may affect their ability to participate effectively Hypertension patients on injectables. Patients with psychiatric illness Critically ill patients. Pregnant and lactating women. Patients who are not willing to give written informed consent.

Design outcomes

Primary

MeasureTime frame
1.To estimate the medication adherence rate among hypertensive patients at SHKM GMC 2.To evaluate the efficacy of an educational module aimed at enhancing medication compliance among non-adherent patients. Timepoint: Baseline, After 4weeks, After 8weeks

Secondary

MeasureTime frame
1. To determine factors linked with adherence to oral antihypertensive medications among hypertensive outpatients at SHKM GMC. 2. To evaluate the relationship between reduction in blood pressure & adherence to oral antihypertensive medication. 3. To report Adverse drug Events to oral antihypertensive drugs Timepoint: Baseline,4 weeks,8weeks

Countries

India

Contacts

Public ContactRajat Bhardwaj

Shaheed Hasan Khan Mewati Government Medical College

nkk999999@rediffmail.com9868257149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026